Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds

被引：62
|
作者：
Nabekura, Tomohiro [1 ]
机构：
[1] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Akiha Ku, Niigata 9568603, Japan
来源：
TOXINS | 2010年 / 2卷 / 06期
关键词：
P-glycoprotein; ABC transporter; anticancer drug; multidrug resistance; phytochemical; cancer chemoprevention; NF-KAPPA-B; P-GLYCOPROTEIN; PHORBOL ESTER; GREEN TEA; CITRUS AURAPTENE; MOLECULAR TARGETS; GRAPEFRUIT JUICE; TUMOR PROMOTION; CARNOSIC ACID; GROWTH ARREST;
D O I：
10.3390/toxins2061207
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
Multidrug resistance is a phenomenon whereby tumors become resistant to structurally unrelated anticancer drugs. P-glycoprotein belongs to the large ATP-binding cassette (ABC) transporter superfamily of membrane transport proteins. P-glycoprotein mediates resistance to various classes of anticancer drugs including vinblastine, daunorubicin, and paclitaxel, by actively extruding the drugs from the cells. The quest for inhibitors of anticancer drug efflux transporters has uncovered natural compounds, including (-)-epigallocatechin gallate, curcumin, capsaicin, and guggulsterone, as promising candidates. In this review, studies on the effects of natural compounds on P-glycoprotein and anticancer drug efflux transporters are summarized.
引用
收藏
页码：1207 / 1224
页数：18
相关论文
共 50 条
  • [41] OVERCOMING MULTIDRUG RESISTANCE IN HUMAN TUMOR-CELLS USING FREE AND LIPOSOMALLY ENCAPSULATED ANTISENSE OLIGODEOXYNUCLEOTIDES
    THIERRY, AR
    RAHMAN, A
    DRITSCHILO, A
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (03) : 952 - 960
  • [42] Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide-doxorubicin conjugate in vitro and in vivo
    Ren, Yuhong
    Wang, Yong
    Zhang, Yufei
    Wei, Dongzhi
    [J]. MOLECULAR PHARMACEUTICS, 2008, 5 (04) : 579 - 587
  • [43] Dynamic Assessment of Mitoxantrone Resistance and Modulation of Multidrug Resistance by Valspodar (PSC833) in Multidrug Resistance Human Cancer Cells
    Shen, Fei
    Bailey, Barbara J.
    Chu, Shaoyou
    Bence, Aimee K.
    Xue, Xinjian
    Erickson, Priscilla
    Safa, Ahmad R.
    Beck, William T.
    Erickson, Leonard C.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (02): : 423 - 429
  • [44] MULTIDRUG-RESISTANCE IN HUMAN CANCER
    LEHNERT, M
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1994, 22 (03) : 239 - 243
  • [45] MULTIDRUG-RESISTANCE IN HUMAN CANCER
    GOTTESMAN, MM
    GOLDSTEIN, LJ
    GALSKI, H
    PASTAN, I
    [J]. BREAST CANCER : PROGRESS IN BIOLOGY, CLINICAL MANAGEMENT AND PREVENTION, 1989, 58 : 117 - 123
  • [46] Overcoming multidrug-resistance in cancer: Statins offer a logical candidate
    Mehta, Narendra G.
    Mehta, Monica
    [J]. MEDICAL HYPOTHESES, 2010, 74 (02) : 237 - 239
  • [47] Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
    Xue, Xue
    Liang, Xing-Jie
    [J]. CHINESE JOURNAL OF CANCER, 2012, 31 (02) : 100 - 109
  • [48] Overcoming Cancer Multidrug Resistance by Codelivery of Doxorubicin and Verapamil with Hydrogel Nanoparticles
    Qin, Ming
    Lee, Yong-Eun Koo
    Ray, Aniruddha
    Kopelman, Raoul
    [J]. MACROMOLECULAR BIOSCIENCE, 2014, 14 (08) : 1106 - 1115
  • [49] Overcoming multidrug resistance in taxane chemotherapy
    Geney, R
    Ungureanu, IM
    Li, DS
    Ojima, I
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (09) : 918 - 925
  • [50] Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?
    Nobili, Stefania
    [J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
12345